tissue plasminogen activator

This page covers all tissue plasminogen activator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting tPA.

Targets

tPA

Phase 3 pipeline (1)

• Standard-dose intravenous tenecteplase · The George Institute · Cardiovascular
  Tenecteplase is a tissue plasminogen activator that works by catalyzing the conversion of plasminogen to plasmin, resulting in the breakdown of blood clots.